Peptide drugs for chronic lymphocytic leukemia (CLL) and other cancers
    1.
    发明申请
    Peptide drugs for chronic lymphocytic leukemia (CLL) and other cancers 审中-公开
    用于慢性淋巴细胞白血病(CLL)和其他癌症的肽药物

    公开(公告)号:US20060198832A1

    公开(公告)日:2006-09-07

    申请号:US11267828

    申请日:2005-11-03

    IPC分类号: A61K38/54 C12N9/99

    摘要: The present invention provides a modified BAD peptide or peptidomimetic which includes an amino acid sequence having at least 60% amino acid identity with SEQ ID NO: 1, where the modified BAD peptide or peptidomimetic has enhanced affinity for Bcl-2 as compared to wild type BAD peptide (SEQ ID NO: 1). Further provided herein is a composition containing a delivery agent and a modified BAD peptide or peptidomimetic which includes an amino acid sequence having at least 60% amino acid identity with SEQ ID NO: 1, where the modified BAD peptide or peptidomimetic has enhanced affinity for Bcl-2 as compared to wild type BAD peptide (SEQ ID NO: 1).

    摘要翻译: 本发明提供了一种修饰的BAD肽或肽模拟物,其包括与SEQ ID NO:1具有至少60%氨基酸同一性的氨基酸序列,其中与野生型相比,修饰的BAD肽或肽模拟物对Bcl-2具有增强的亲和力 BAD肽(SEQ ID NO:1)。 本文进一步提供的是含有递送剂和修饰的BAD肽或肽模拟物的组合物,其包含与SEQ ID NO:1具有至少60%氨基酸同一性的氨基酸序列,其中修饰的BAD肽或肽模拟物对Bcl具有增强的亲和力 -2与野生型BAD肽(SEQ ID NO:1)相比。

    Compounds that regulate apoptosis
    3.
    发明申请
    Compounds that regulate apoptosis 失效
    调节细胞凋亡的化合物

    公开(公告)号:US20070054863A1

    公开(公告)日:2007-03-08

    申请号:US11433783

    申请日:2006-05-11

    摘要: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and related Bcl-2 family members are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing or preventing apoptosis are described, together with methods for identifying molecules that induce or prevent apoptosis through interaction with Bcl-2-family members. Methods for treatment of proliferative diseases and neurodegenerative diseases using the modulators of Bcl-2 and related family members are also disclosed.

    摘要翻译: 鉴定了调节抗凋亡蛋白如Bcl-2和相关Bcl-2家族成员功能的化合物。 这些化合物具有将Bcl-2家族成员蛋白的活性从抗凋亡转化为促凋亡的能力。 描述诱导或预防凋亡的方法,以及用于鉴定通过与Bcl-2家族成员相互作用诱导或预防凋亡的分子的方法。 还公开了使用Bcl-2和相关家族成员的调节剂治疗增殖性疾病和神经变性疾病的方法。

    METHODS OF REGULATING APOPTOSIS
    4.
    发明申请
    METHODS OF REGULATING APOPTOSIS 审中-公开
    调节疫苗的方法

    公开(公告)号:US20100292145A1

    公开(公告)日:2010-11-18

    申请号:US12815893

    申请日:2010-06-15

    IPC分类号: A61K38/18 C12N5/071 A61P35/00

    摘要: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and related Bcl-2 family members are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing or preventing apoptosis are described, together with methods for identifying molecules that induce or prevent apoptosis through interaction with Bcl-2-family members. Methods for treatment of proliferative diseases and neurodegenerative diseases using the modulators of Bcl-2 and related family members are also disclosed.

    摘要翻译: 鉴定了调节抗凋亡蛋白如Bcl-2和相关Bcl-2家族成员功能的化合物。 这些化合物具有将Bcl-2家族成员蛋白的活性从抗凋亡转化为促凋亡的能力。 描述诱导或预防凋亡的方法,以及用于鉴定通过与Bcl-2家族成员相互作用诱导或预防凋亡的分子的方法。 还公开了使用Bcl-2和相关家族成员的调节剂治疗增殖性疾病和神经变性疾病的方法。

    Compounds that regulate apoptosis
    5.
    发明授权
    Compounds that regulate apoptosis 失效
    调节细胞凋亡的化合物

    公开(公告)号:US07745574B2

    公开(公告)日:2010-06-29

    申请号:US11433783

    申请日:2006-05-11

    IPC分类号: C07K14/00 A61K38/16

    摘要: Compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and related Bcl-2 family members are identified. These compounds have the ability to convert the activity of Bcl-2-family member proteins from anti-apoptotic to pro-apoptotic. Methods for inducing or preventing apoptosis are described, together with methods for identifying molecules that induce or prevent apoptosis through interaction with Bcl-2-family members. Methods for treatment of proliferative diseases and neurodegenerative diseases using the modulators of Bcl-2 and related family members are also disclosed.

    摘要翻译: 鉴定了调节抗凋亡蛋白如Bcl-2和相关Bcl-2家族成员功能的化合物。 这些化合物具有将Bcl-2家族成员蛋白的活性从抗凋亡转化为促凋亡的能力。 描述诱导或预防凋亡的方法,以及用于鉴定通过与Bcl-2家族成员相互作用诱导或预防凋亡的分子的方法。 还公开了使用Bcl-2和相关家族成员的调节剂治疗增殖性疾病和神经变性疾病的方法。